The U.S. Food and Drug Administration (FDA) has authorized using donated blood plasma to treat COVID-19 patients. Eric Sorensen explains why critics have some reservations about this.
- Idaho university ‘deeply troubled’ by students contracting COVID-19 to sell plasma
- WHO cautions on coronavirus plasma treatment: ‘The results are not conclusive’
- Trump announces emergency authorization of plasma treatment for coronavirus